Learn more

GENELABS TECH INC

Overview
  • Total Patents
    453
About

GENELABS TECH INC has a total of 453 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CANCER RES TECH LTD, SICHUAN KELUN BOTAI BIOMEDICAL CO LTD and PROLIFIX LTD.

Patent filings per year

Chart showing GENELABS TECH INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Roberts Christopher Don 165
#2 Schmitz Franz Ulrich 76
#3 Dyatkina Natalia B 75
#4 Griffith Ronald Conrad 75
#5 Botyanszki Janos 72
#6 Keicher Jesse D 68
#7 Shi Dong-Fang 57
#8 Fry Kirk E 45
#9 Reyes Gregory R 43
#10 Kim Jungsuh P 37

Latest patents

Publication Filing date Title
US2010204265A1 Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
US2009197880A1 Anti-viral compounds, compositions, and methods of use
TW200927751A Antiviral compounds
WO2009029729A1 Amino tricyclic-nucleoside compounds, compositions, and methods of use
US2009317360A1 Anti-viral inhibitors and methods of use
US2008193411A1 Anti-viral Compounds
US2008181866A1 Amido Anti-viral Compounds
US2008045498A1 Polycyclic viral inhibitors
US2008051384A1 Antiviral agents
BRPI0714346A2 Antiviral agents
BRPI0619733A2 n- (6-membered aromatic ring) -amido antiviral compounds
CN101331125A N-(5-membered aromatic ring)-amido anti-viral compounds
US2007032488A1 6-Membered aryl and heteroaryl derivatives for treating viruses
MY142331A Bicyclic heteroaryl derivatives for treating viruses
MX2007016144A Heteroaryl derivatives for treating viruses.
US2006241064A1 Nucleoside compounds for treating viral infections
WO2007084157A2 Nucleoside prodrugs for treating viral infections
WO2006102594A1 Nucleoside prodrugs for treating viral infections
CN101142226A Tricyclic-nucleoside prodrugs for treating viral infections
WO2006121468A1 5-nitro-nucleoside compounds for treating viral infections